Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Glucose Meter Manufacturing in the US - Industry Market Research Report
... diabetes. The American Diabetes Association (ADA) reports that there are about 8.5 million individuals with undiagnosed diabetes, providing manufacturers with a large potential customer base. Diabetic patients use glucose meters to manage their glucose levels, ... Read More
-
Hemoglobin A1c Testing Devices and Kits Market
... Hemoglobin A1c Testing Devices & Kits products, technology, and their current and historical market revenues. This report discusses the implications of the trends mentioned above in the context of the current size and growth of ... Read More
-
Insulin Markets in China
... a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment ... Read More
-
Diabetic Food Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... to reach US$ 17.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.7% during 2023-2028. Diabetic foods are dietary products that have low carbohydrate and sugar content and assist in controlling glucose levels in ... Read More
-
Diabetes Care Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... the market to reach US$ 47.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.9% during 2023-2028. Diabetes care devices refer to equipment used to monitor or determine blood sugar levels. Smart insulin pens, ... Read More
-
Diabetes Diagnostics
... US$59.4 Billion by 2030, growing at a CAGR of 8.6% over the period 2022-2030. Test Strips, one of the segments analyzed in the report, is projected to record 8.7% CAGR and reach US$14.7 Billion by ... Read More
-
Global Markets for Diabetes Therapeutics and Diagnostics
... terms and by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided ... Read More
-
Medical Foods Market Research Report Forecast to 2030
... consistent ailments, creating energizing needs among people, and uncovering issues about prebiotics and probiotic things are driving market advancement. Consistent afflictions, for instance, cardiovascular, neurological, urological, and overpowering ailments are growing from one side of ... Read More
-
Wearable Injectors Market (7th Edition), 2017-2022 (Historical Trends) and 2023-2035 (Forecasted Estimates)
... grow at compounded annual growth rate (CAGR) of 9.01% during the forecast period. With the increasing population, the incidence rates of various chronic diseases, such as diabetes, autoimmune diseases, cardiovascular diseases, and oncological diseases, are ... Read More
-
Well-Being Platform Market Forecast to 2030 - Global Analysis by Service (Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition & Weight Management, Stress Management, Comprehensive Well-Being, and Others), Category (Fitness and Nutrition Consultant, Psychological Therapists, and Organizations/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organizations, and Home Use), and Geography
... Psychological Therapists, and Organizations/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organizations, and Home Use), and Geography The well-being platform market is expected to grow from US$ 449.21 billion in ... Read More
-
Asia-Pacific Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to USD 20.99 billion by 2028, at a CAGR of 2.68% during the forecast period (2023-2028). The Asia-Pacific region has witnessed an astounding increase in the prevalence of diabetes in patients, in recent years. The ... Read More
-
North America Insulin Pens Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... expected to reach USD 14.64 billion by 2028, growing at a CAGR of 4.87% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the North America Insulin Pens Market. Type-1 diabetes patients are ... Read More
-
Europe Insulin Infusion Pumps Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... expected to reach USD 650.23 million by 2028, growing at a CAGR of 3.85% during the forecast period (2023-2028). The COVID-19 pandemic has had a significant impact on the market studied. Type-1 diabetes patients have ... Read More
-
North America Insulin Infusion Pumps Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... and is expected to reach USD 3.56 billion by 2028, growing at a CAGR of 6.18% during the forecast period (2023-2028). In North America, till April 2022, the United States is having the highest COVID ... Read More
-
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GlL[-1) Receptor Agonist Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... Market size is expected to grow from USD 9.20 billion in 2023 to USD 11.52 billion by 2028, at a CAGR of 4.61% during the forecast period (2023-2028). The COVID-19 epidemic has significantly affected the ... Read More
-
Insulin Glargine Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 1.97 billion by 2028, growing at a CAGR of 6.28% during the forecast period (2023-2028). The COVID-19 pandemic has resulted in a surge in diabetic complexities, which is driving the insulin demand in the ... Read More
-
Middle East And Africa Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... from USD 1.90 billion in 2023 to USD 2.20 billion by 2028, at a CAGR of 2.99% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the Middle East and Africa Insulin Delivery ... Read More
-
North America Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... in 2023 to USD 18.49 billion by 2028, at a CAGR of 5.06% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the North America Insulin Delivery Devices Market. Type-1 diabetes patients are ... Read More
-
North America Human Insulin Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... and is expected to reach USD 13.50 billion by 2028, growing at a CAGR of 3.91% during the forecast period (2023-2028). In North America diabetes incidence for type 2 diabetes as well as other diabetes, ... Read More
-
Europe Insulin Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... reach USD 7.20 billion by 2028, growing at a CAGR of 4.89% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the European Insulin Drugs Market. Type-1 diabetes patients are impacted more during ... Read More
-
Europe Insulin Pens Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... reach USD 2.29 billion by 2028, growing at a CAGR of 1.45% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the European Insulin Pens Market. Type-1 diabetes patients are impacted more during ... Read More
-
Human Insulin Drugs And Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... in 2023, and is expected to reach USD 78.08 billion by 2028, growing at a CAGR of 3.73% during the forecast period (2023-2028). Diabetes mellitus is considered a risk factor for increasing COVID-19. During the ... Read More
-
Short-Acting Insulin Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... by 2028, at a CAGR of 3.46% during the forecast period (2023-2028). There is not enough data saying that diabetes people are more likely to get COVID-19 than other healthy people, individuals with any kind ... Read More
-
Europe Insulin Syringe Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... reach USD 117.35 million by 2028, growing at a CAGR of 1.20% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the Europe Insulin Syringe Market. People with diabetes have a weak immune ... Read More
-
North America Insulin Syringe Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... expected to reach USD 272.83 million by 2028, growing at a CAGR of 1.70% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the North America Insulin Syringe Market. People with diabetes have ... Read More
Research Assistance
